Renal cell carcinoma CT: Difference between revisions
(Created page with "{{CMG}} {{Renal cell carcinoma}} ==Overview== ==Radiology== ===Radiology=== The characteristic appearance of renal cell carcinoma (RCC) is a solid renal lesion which distur...") |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== | ==CT == | ||
TO detect | |||
* Cerebral metastases | |||
* Cutaneous metastasis | |||
* Lung metastases | |||
===Radiology=== | ===Radiology=== | ||
Revision as of 20:38, 27 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma CT On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma CT |
|
Risk calculators and risk factors for Renal cell carcinoma CT |
Overview
CT
TO detect
- Cerebral metastases
- Cutaneous metastasis
- Lung metastases
Radiology
The characteristic appearance of renal cell carcinoma (RCC) is a solid renal lesion which disturbs the renal contour. It will frequently have an irregular or lobulated margin. 85% of solid renal masses will be RCC. 10% of RCC will contain calcifications, and some contain macroscopic fat (likely due to invasion and encasement of the perirenal fat). Following intravenous contrast administration (computed tomography or magnetic resonance imaging), enhancement will be noted, and will increase the conspicuity of the tumor relative to normal renal parenchyma.
Patient #1
Patient #2
Patient #3
Patient #4
At diagnosis, 30% of renal cell carcinoma has spread to that kidney's renal vein, and 5-10% has continued on into the inferior vena cava[1].
Percutaneous biopsy can be performed by a radiologist using ultrasound or computed tomography to guide sampling of the tumor for the purpose of diagnosis. However this is not routinely performed because when the typical imaging features of renal cell carcinoma are present, the possibility of an incorrectly negative result together with the risk of a medical complication to the patient make it unfavorable from a risk-benefit perspective.This is not completely accurate, there are new experimental treatments.
References
- ↑ Oto A, Herts BR, Remer EM, Novick AC. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment. AJR Am J Roentgenol. 1998 Dec;171(6):1619-24. PMID 9843299.